Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0X9PW
|
||||
| Former ID |
DIB006862
|
||||
| Drug Name |
Tesmilifene
|
||||
| Synonyms |
DPPE; DPPE hydrocloride; Tesmilifene hydrochloride; BMS 217380-01; BMS-217380; BMY-33419; DPPE, BMS; YMB-1002; Anticancer, BMS/Manitoba Univ/MTCR
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Breast cancer; Prostate cancer [ICD9: 174, 175, 185; ICD10:C50, C61] | Discontinued in Phase 2 | [545850] | ||
| Company |
YM Biosciences
|
||||
| Formula |
C19H25NO
|
||||
| Canonical SMILES |
c1(Cc2ccccc2)ccc(cc1)OCCN(CC)CC
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Histamine receptor | Target Info | Modulator | [531060] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.